Status:

COMPLETED

Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia

Lead Sponsor:

Laboratoires Techni Pharma

Conditions:

Dyschesia

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia.

Eligibility Criteria

Inclusion

  • Male or female aged from 18 to 75 years old,
  • Writing consent to take part in the study,
  • Patient with a dyschesia according to Rome III criteria
  • An intensity of the inconfort using a VAS (0 (no inconfort) to 100 mm (maximal and no supportable inconfort)) equal or over 40 mm

Exclusion

  • Patient suffering of neurologic affection,
  • Rectal diseases including :
  • Current anal ou peri-anal pain,
  • Current organic injury of colon or rectum,
  • Current anal injury,
  • Current rectal Prolapse,
  • Current haemorrhoid,
  • Colon inflammatory disease (ulcero haemorrhagic recto colitis, Crohn disease…),
  • Current ano-recto-colon stenosis (anastomosis, scarring ...)
  • Patient undergone pain killers (WHO level II (except dextropropoxyphen) and III) during the last 8 days,
  • Patient undergone anti-depressants except if this treatment is regular for at least 15 days and it won't be modified during the study,
  • Patient with a constipation treatment except if this treatment is regular for at least 15 days and it won't be modified during the study
  • Intolerance to Eductyl® or to one of its components (potassium tartarate acid, sodium bicarbonate, solid hemisynthethic glycerides, soya lecithin, talc)
  • Use of Eductyl® during the previous 15 days (over 5 days in the last 15 days),
  • Patient already included in clinical trial in the last month,
  • Pregnant or breast feeding woman,
  • Woman of childbearing potential without contraception,
  • Patient unable to read and write.

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2012

Estimated Enrollment :

306 Patients enrolled

Trial Details

Trial ID

NCT01243723

Start Date

November 1 2010

End Date

June 1 2012

Last Update

March 19 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Foch, Service de Chirurgie Générale et Digestive

Suresnes, France, 92151

Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia | DecenTrialz